Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > PURCHASE AGREEMENT
View:
Post by chris579457 on Dec 16, 2020 9:55am

PURCHASE AGREEMENT

INVICTUS ANNOUNCES SIGNING OF A PURCHASE AGREEMENT
Canada Newswire DEC 16, 2020 08:30 AM EST

VANCOUVER, BC Dec. 16, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the " Company ") announced today that it has entered into an agreement (the " Subscription Agreement ") for the issuance of 1,121,248,467 Invictus common shares (the " Subscribed Shares "). The Subscribed Shares will be equal to 90% of Invictus' issued share capital on completion of the transaction.  As a result, on completion of the transaction existing shareholders will retain an aggregate 10% interest in the Company.  It is anticipated that the subscription proceeds will be used to repay existing secured creditors of the Company, to pay costs associated with the CCAA proceedings involving the Company and its subsidiaries and to fund a plan of compromise and arrangement (the " Plan ") with the unsecured creditors of the Company.  None of the subscription proceeds will be made available to existing shareholders of the Company.

The subscriber of the Subscribed Shares is Invictus Strategic Investment Inc. (the " Investor "), a privately-owned company that is unrelated to the Company and its directors and officers.

Completion of the Subscription Agreement is subject to condition precedents including Court approval of the transaction and the Plan being approved by the creditors of the Company and the Court in the CCAA proceedings currently underway involving the Company and certain of its subsidiaries.

The Company filed a motion for a court order to present the Plan to the creditors of the Company and subject to receiving certain approvals, plans to seek a sanction order from the Court approving the implementation of Plan.

Comment by chris579457 on Dec 17, 2020 1:28pm
Wondering if any one can help to translate this to English   New company will buy the leftovers of Invictus They will be given 1,121,248,467 after purchase That will devaluate the company and we will hold only 10% of it Total shares should be around 1,121,248,467  plus existing shares 124,583,163 = 1,245,831,630   -Then I believe they will reverse split on this ...more  
Comment by JackCross on Dec 18, 2020 1:16pm
That seems like a pretty spot on translation. They need to issue shares to a point where the outstanding shares become 10% of the total shares listed. Whatever comes after that is down to management. I'll be happy if the ability to trade comes back - and management appears to be competent. 
Comment by sanjayp on Dec 17, 2020 2:09pm
what does it mean to investors holding shares of Gene / invictus ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities